BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2408528)

  • 1. Chronic lymphocytic leukemia. Recent advances in biology and treatment.
    Gale RP; Foon KA
    Ann Intern Med; 1985 Jul; 103(1):101-20. PubMed ID: 2408528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of chronic lymphocytic leukemia.
    Gale RP; Foon KA
    Semin Hematol; 1987 Oct; 24(4):209-29. PubMed ID: 3317850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging and therapy of chronic lymphocytic leukemia.
    Foon KA; Gale RP
    Semin Hematol; 1987 Oct; 24(4):264-74. PubMed ID: 2446394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic markers in childhood acute lymphocytic leukemia.
    Crist WM; Grossi CE; Pullen DJ; Cooper MD
    Semin Oncol; 1985 Jun; 12(2):105-21. PubMed ID: 3892693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in biology and treatment of chronic lymphocytic leukemia].
    Robak T
    Postepy Hig Med Dosw; 1988; 42(5):483-522. PubMed ID: 3076236
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
    Aisenberg AC; Wilkes BM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immunotyping in chronic lymphocytosis: review of the natural history of the condition in 145 adult patients.
    Tefferi A; Li CY; Phyliky RL
    Mayo Clin Proc; 1988 Aug; 63(8):801-6. PubMed ID: 2456433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia.
    Stahl RL; Silber R
    Clin Geriatr Med; 1985 Nov; 1(4):857-67. PubMed ID: 3830389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolymphocytic leukaemia.
    Catovsky D
    Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic leukapheresis in a patient with prolymphocytic transformation of B-cell chronic lymphocytic leukemia.
    Steenssens L; Van Camp B
    Int J Artif Organs; 1984 May; 7(3):139-42. PubMed ID: 6610651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphoid leukemias: recent advances in biology and therapy.
    Foon KA
    Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influential T cell in B-cell neoplasms.
    Kay NE; Oken MM; Perri RT
    J Clin Oncol; 1983 Dec; 1(12):810-6. PubMed ID: 6230420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of helper activity for B-lymphocyte differentiation with lymphocytes having both SRBC and complement receptors in a patient with lymphoproliferative disease.
    Chiao JW; Pahwa S; Arlin ZA; Good RA
    Clin Immunol Immunopathol; 1979 Jun; 13(2):125-35. PubMed ID: 313300
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia and other chronic lymphoid proliferations: surface marker phenotypes and clinical correlations.
    Dillman RO; Beauregard JC; Lea JW; Green MR; Sobol RE; Royston I
    J Clin Oncol; 1983 Mar; 1(3):190-7. PubMed ID: 6607975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
    Besa EC
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
    [No Abstract]   [Full Text] [Related]  

  • 18. T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells.
    Thien SL; Catovsky D; Oscier D; Goldman JM; van der Reijden HJ; Melief CJ; Rümke HC; Ten Berge RJ; von dem Borne AE
    Clin Exp Immunol; 1982 Mar; 47(3):670-6. PubMed ID: 6211309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders.
    Foroni L; Catovsky D; Luzzatto L
    Leukemia; 1987 Apr; 1(4):389-92. PubMed ID: 3118109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia: new insights into biology and therapy.
    Foon KA; Rai KR; Gale RP
    Ann Intern Med; 1990 Oct; 113(7):525-39. PubMed ID: 2203293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.